Skip to main content
Log in

The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effect of clonidine withdrawal on the brain norepinephrine system was studied in the rat. Clonidine suppresses brain total 3-methoxy-4-hydroxyphenylglycol (MHPG) significantly and no tolerance to this effect was observed up to 21 days. Cessation of clonidine treatment resulted in an elevation in the level of brain total MHPG. The suitability of the clonidine withdrawal syndrome as a model of bipolar depression is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bond, P. A., Jenner, F. A., Sampson, G. A.: Daily variations of the urine content of MHPG in two manic-depressive patients. Psychol. Med. 2, 81–85 (1972)

    Google Scholar 

  • Greenspan, K., Schildkraut, J. J., Gordon, E. K., Baer, L., Aronoff, M. D., Durell, J.: Catecholamine metabolism in affective disorders III. J. Psychiat. Res. 7, 171–183 (1970)

    Google Scholar 

  • Hansson, L., Hunyor, M., Julius, S., Hoobler, S.: Blood pressure crisis following withdrawal of clonidine (Catapress, Catapresan) with specific reference to arterial and urinary catecholamine levels and suggestions for acute management. Amer. Heart J. 85, 605–610 (1973)

    Google Scholar 

  • Hokfelt, B., Hedeland, H., Dymling, J. F.: Studies on catecholamines, renin and aldosterone following catapresan [2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride] in hypertensive patients. Eur. J. Pharmacol. 10, 389–397 (1970)

    Google Scholar 

  • Jones, F. D., Maas, J. W., Dekirmenjian, H., Fawcett, J. A.: Urinary catecholamines during behavioral changes in a patient with manic-depressive cycles. Science 179, 200–202 (1973)

    Google Scholar 

  • Maas, J. W., Fawcett, J., Dekirmenjian, H.: 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depressive states. Arch. Gen. Psychiatry 19, 129–134 (1968)

    Google Scholar 

  • Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509–522 (1965)

    Google Scholar 

  • Simpson, F. O.: Hypertension and depression: interrelated problems in therapy. J. R. Coll. Physicians London 6, 14–24 (1971)

    Google Scholar 

  • Svensson, T. H., Strömbom, U.: Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 83–87 (1977)

    Google Scholar 

  • Takahashi, S., Godse, D. D., Warsh, J. J., Stancer, H. C.: A gas chromatographic-mass spectrometric (GS-MS) assay for 3-methoxy-4-hydroxyphenethyleneglycol and vanilmandelic acid in human serum. Clin. Chim. Acta 81, 183–192 (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Ontario Mental Health Foundation Research Fellow 1977–1978

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, S.W., Helmeste, D.M. & Stancer, H.C. The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain. Psychopharmacology 61, 11–12 (1979). https://doi.org/10.1007/BF00426802

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426802

Key words

Navigation